RxSight: Funding, Investors & Team (Oct 2026)
RxSight, Inc. is a company focused on enhancing post-cataract surgery vision for patients. Their innovative technology, the RxSight Light Adjustable Lens system, includes the Light Adjustable Lens (LAL®), Light Delivery Device (LDD), and related accessories. This is the only intraocular lens technology available that allows doctors to personalize and enhance patients' vision after cataract surgery. The LAL now includes ActivShield™ technology, which provides UV protection within the lens.
RxSight has raised $165M across 2 funding rounds on record, the most recent an undisclosed round of $115M announced in May 2024.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
RxSight Company Profile and Key Stats
Latest funding round on record: May 2024.
RxSight Funding Rounds
RxSight raised $50.0M in an undisclosed round announced in Feb 2023.
1.3 years later, an undisclosed round of $115M was announced in May 2024.
RxSight Founders and Leadership Team
No contact details are on record for this team yet.
RxSight Funding Compared to Other Biotechnology Startups
RxSight's latest round of $115M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like RxSight in Biotechnology and Aliso Viejo
Companies Similar to RxSight
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
RxSight Funding FAQs
What does RxSight do?
RxSight, Inc. is a company focused on enhancing post-cataract surgery vision for patients. Their innovative technology, the RxSight Light Adjustable Lens system, includes the Light Adjustable Lens (LAL®), Light Delivery Device (LDD), and related accessories. This is the only intraocular lens technology available that allows doctors to personalize and enhance patients' vision after cataract surgery. The LAL now includes ActivShield™ technology, which provides UV protection within the lens.
How much funding has RxSight raised?
RxSight has raised $165M across 2 rounds on record. The most recent is an undisclosed round of $115M announced in May 2024.
When did RxSight last raise funding?
RxSight's most recent funding round on record is an undisclosed round of $115M, announced in May 2024.
Who founded RxSight?
FundedIQ lists Daniel Schwartz (Founder), Robert Grubbs (Founder) at RxSight.
Where is RxSight headquartered?
RxSight is based in Aliso Viejo, California, United States.
How many employees does RxSight have?
RxSight is in the 251-500 employee band.
How does RxSight's funding compare to other Biotechnology startups?
RxSight's latest round of $115M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's RxSight Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for RxSight is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.